The collaboration combines glass syringe platforms and elastomeric components to generate early system-level performance data, supporting pharmaceutical companies in selecting packaging configurations for sensitive biologics and injectable therapies.
Aptar Pharma and Stevanato Group have announced a collaboration to help pharmaceutical and biotechnology companies accelerate the evaluation and selection of pre-filled syringe (PFS) systems for complex injectable therapies.
